Article Commentary: Explaining the Shift to Value-Based Reimbursement in the Setting of Dermatology and Psoriasis. Issue 1 (December 2016)

• Record Type: Journal Article
• Authors: Farahnik, Benjamin; Nakamura, Mio; Bhutani, Tina; Koo, John
• Is Part Of: Journal of psoriasis and psoriatic arthritis. Volume 2:Issue 1(2016)
• Page Start: 5
• Page End: 8
• Publication Date: 2016-12
• Subjects: value-based reimbursement -- value-based care -- value-based purchasing -- reimbursement mechanisms -- Medicare -- health care -- psoriasis -- dermatology; Psoriasis -- Periodicals; Psoriasis -- Treatment -- Periodicals; Psoriatic arthritis -- Periodicals; Psoriatic arthritis -- Treatment -- Periodicals; Electronic journals; 616.722
• DOI: 10.1177/247553031600200101
• Languages: English
• ISSNs: 2475-5303

Abstract

The Department of Health and Human Services has announced a campaign for transitioning Medicare reimbursement from volume to value. A budget-neutral Value-Based Payment Modifier has been implemented that provides for differential payment to physicians based upon the quality of care delivered. The value modifier will be based partially on physician participation in the Physician Quality Reporting System (PQRS), which allows for reporting of information on quality of care to Medicare. The information reported includes both medical data and patient-reported experiences with health care providers. Starting in 2017, the value modifier payment adjustment will apply to all physicians who make Medicare part B fee-for-service charge claims. Physicians who do not participate in the PQRS and satisfy reporting requirements may be assessed negative adjustments to their payments. Dermatologists in particular will be impacted by these changes, as skin diseases, especially psoriasis, account for a significant economic burden in the U.S.